Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer. - Wikidata - wikimedia - TriplyDB

Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.

Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.

http://www.wikidata.org/entity/Q34616067

about

Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer Relevance of tumor-infiltrating lymphocytes in breast cancer Immune DNA signature of T-cell infiltration in breast tumor exomes.Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.The Role of Neoadjuvant Trials in Drug Development for Solid Tumors.Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.Objective measurement and clinical significance of TILs in non-small cell lung cancer.RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence.Evaluating the effect of immune cells on the outcome of patients with mesothelioma.Immunodetection of Human LINE-1 Expression in Cultured Cells and Human Tissues.Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.Adaptive immunity programmes in breast cancer.The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.TissueCypher(™): A systems biology approach to anatomic pathology.Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.Data integration from pathology slides for quantitative imaging of multiple cell types within the tumor immune cell infiltrate.Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer.Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis.B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome.New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer.Mechanisms of immune evasion in breast cancer.A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.Tumor infiltrating CD19 B lymphocytes predict prognostic and therapeutic benefits in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

P2860

Q26745446-30712C06-E9BF-4ED2-B49F-0DC9B9F7E47E Q26795598-AD30B678-F31A-4F7B-9B45-13674F23B4E4 Q30377226-5C8A9EF0-883A-41E4-BAB4-01BC6786DCCC Q33584033-901E3612-7CD1-4371-80E7-134E1F177B53 Q33886353-23BE5D78-9EBE-44D1-ABA8-4A3CCC1D4AA4 Q35251561-D53E62FF-0BDB-4915-9800-EE0780012B60 Q36047422-33F45AB9-717D-45A3-8C14-CD0316C884CA Q36693087-485E11F3-C182-4FE5-8682-E7057EF9368D Q36866538-71BB1E77-4AFA-40DA-9F1D-9CB99EDEFD7B Q37423348-D07599BF-F0AB-46DD-B723-2F07D379F451 Q37600589-7304FF7F-2A4E-4240-96C9-3DEABFA448BA Q38619743-74387B46-51DE-42C4-974C-9D889C4ADBCD Q38792658-9EECC392-B962-4FD9-B548-BB07CFDD62BF Q38823649-B5279367-9D29-420E-BF9B-A7965A9A69F2 Q38888197-05BAAB1C-A7FD-4C90-AD70-4BBB00312C74 Q38937896-61278DEB-1B24-4544-81EE-5D12887EC376 Q39172481-E1A2ECD9-43A8-408F-ADA6-6241D9BC89D7 Q40319118-BE97D114-382B-473A-9140-854D67196411 Q41291930-C0B3C88A-0983-479A-9B43-83A051452E8C Q41705524-EDA2CD1C-31D9-45AE-9E67-8E064B8C5EF1 Q41850484-224AEB1E-EAA5-48C8-9997-E77E89E5B740 Q42393214-4A345770-1A2C-475C-8B49-288B6F04A70D Q42690881-06CDD64A-4023-4765-9019-0887DF24482D Q47118505-563AC33D-2577-48B5-8598-C8B811B6C6FF Q50983217-E5212A2C-BF03-4D64-AC55-DC1113489692 Q52097229-92E368B2-D97C-4C59-B59F-0E3E807ED855 Q52641617-693E8867-0C03-41FE-93F0-27B980C99D19 Q55345031-A88CA2FA-7E4E-4B88-8C5F-BE282840C666 Q55347716-C5C28056-C9B8-4277-B35E-BA68969F5647 Q55456412-887ADA27-2169-4D9A-9981-6B346AF02070 Q57135155-0DA5B0AA-7658-4878-8029-741F4EEE33EF Q57152794-CE320398-7C02-4976-AC87-05338C22E314 Q57816466-C281F3C1-7A0E-406B-92C9-1AB3C2DA2546

P2860

Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.

http://www.wikidata.org/entity/Q34616067

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@ast

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@en

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@nl

type

label

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@ast

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@en

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@nl

prefLabel

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@ast

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@en

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@nl

P1433

Q34616067-3447EFC3-ED7B-43E7-B182-2AA17A636F13

P1476

Q34616067-EE69094C-60B5-4665-83EE-5C680CBC1BF0

P2093

Q34616067-1DBC11A7-ACD9-4CE5-8504-CE5C56098048

Q34616067-25B01A65-6C44-45A1-8384-9FF723C6191B

Q34616067-3A30DEA1-8FA7-43AE-9CC9-70A99A6349B2

Q34616067-74A565E1-550F-4FC7-A461-3F37046B43C8

Q34616067-8F9DF62B-122B-4DBB-BB6A-E4C0753F8C58

Q34616067-E47EF8F7-B811-4A03-A22E-66246341C212

P2860

Q34616067-05AE453A-808E-4F68-A471-CAA307A172E8

Q34616067-15659A80-4683-4983-9A76-F9AA01BDB524

Q34616067-1566EAA0-8C20-4CEC-9B58-47923FAB8BF9

Q34616067-1F3E5FAF-DAA8-4F95-8132-ACEB8087E6E9

Q34616067-28B524C9-B16A-4C7A-81D9-2FBED98D1B38

Q34616067-31333255-35F2-4B26-AC83-0BD61DAB561F

Q34616067-33538FEF-5B64-4AB8-944C-C55C7F641531

Q34616067-3C865CEF-5B3C-4FC7-91C6-0ADBAF7EA8E3

Q34616067-3DA91F58-669C-439B-9FAF-341D5E25E269

Q34616067-41A6E419-B503-4027-BBCF-FCCF62B0AA4D

P304

Q34616067-68D7BF56-FB37-4197-B5CE-52C5DDA3664E

P31

Q34616067-2FE494F0-3536-4B8B-B064-E3E00567C25D

P356

Q34616067-F78D71DB-3439-4119-B37A-8FDD1D98D042

P407

Q34616067-2AA8DD62-8D8A-433D-9CF9-8430D8B3FCCA

P433

Q34616067-C1DDA381-FDCD-4361-86E7-249B9C9B0301

P478

Q34616067-5CAB9928-86BE-48F1-A125-ACE4FF1A3DBD

P577

Q34616067-44031E7D-FC27-40FE-81C8-3CD9A57734E3

P698

Q34616067-89D7399B-8865-4C28-8048-E7125AE1E6DC

P921

Q34616067-6C297FF4-BE8B-491E-9A06-1F968AEBD289

P932

Q34616067-6553159C-EF15-492B-85F8-FA0F58B4C714

P356

1078-0432.CCR-14-1622

P1433

Clinical Cancer Research

P1476

Multiplexed quantitative analy ...... chemotherapy in breast cancer.

@en

P2093

Christian Nixon

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Donald R Lannin

http://www.w3.org/2001/XMLSchema#string

Hallie Wimberly

http://www.w3.org/2001/XMLSchema#string

Jason R Brown

http://www.w3.org/2001/XMLSchema#string

Veerle Bossuyt

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer classification using the Immunoscore: a worldwide task force

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Estimation of immune cell densities in immune cell conglomerates: an approach for high-throughput quantification

Digital genomic quantification of tumor-infiltrating lymphocytes.

Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders

New flow cytometric assays for monitoring cell-mediated cytotoxicity

Leukocyte composition of human breast cancer

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor

P304

5995-6005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-1622

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25255793

http://www.w3.org/2001/XMLSchema#string

P921

P932

4252785

http://www.w3.org/2001/XMLSchema#string